Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.01 billion.
Market Cap
1.14T
Revenue
110.01B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.51%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 113.59B | -0.10% | 1,893,353 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.41B | -1.08% | 2,187,509 | 14.92B |
| 3 | ARGX | argenx SE | 51.98B | -0.30% | 192,484 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.32B | -1.01% | 2,278,038 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 33.50B | 1.84% | 6,663,698 | - |
| 6 | RPRX | Royalty Pharma plc | 32.11B | 2.35% | 17,987,883 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 32.01B | -0.92% | 174,818 | 5.70B |
| 8 | BNTX | BioNTech SE | 24.26B | 2.69% | 1,496,179 | 3.23B |
| 9 | INSM | Insmed Incorporated | 23.17B | -1.35% | 4,534,657 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 21.57B | 0.37% | 7,734,934 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.33B | -0.78% | 2,902,984 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.72B | -0.80% | 6,318,429 | 2.23B |
| 13 | GMAB | Genmab A/S | 16.34B | -2.63% | 2,199,583 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.84B | 0.47% | 1,766,241 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.92B | -5.63% | 1,266,085 | 998.25M |
| 16 | SMMT | Summit Therapeutics Inc. | 13.61B | 0.75% | 7,214,025 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.98B | -3.20% | 3,052,318 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.69B | -1.89% | 2,950,641 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.64B | -1.07% | 1,673,265 | 1.06B |
| 20 | AXSM | Axsome Therapeutics, Inc. | 12.07B | 0.71% | 913,855 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.46B | -3.62% | 435,976 | 1.13B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | 8.63% | 5,467,663 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.97B | -1.44% | 1,441,917 | 622.01M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.56B | 2.42% | 1,886,454 | 5.67M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.42B | -0.07% | 1,844,584 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.76B | -0.75% | 424,815 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.11B | -0.41% | 226,288 | 417.30M |
| 28 | NUVL | Nuvalent, Inc. | 8.72B | 1.02% | 1,169,579 | - |
| 29 | TECH | Bio-Techne Corporation | 8.09B | 1.65% | 2,928,101 | 1.21B |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.89B | -2.41% | 1,917,385 | 1.51B |
| 31 | IBRX | ImmunityBio, Inc. | 7.88B | -2.59% | 15,617,375 | 140.98M |
| 32 | CORT | Corcept Therapeutics Incorporated | 7.46B | 1.62% | 775,015 | 769.10M |
| 33 | PCVX | Vaxcyte, Inc. | 7.42B | 0.67% | 1,414,021 | - |
| 34 | IMVT | Immunovant, Inc. | 6.84B | -0.60% | 1,808,441 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.70B | -0.05% | 587,342 | 51.48M |
| 36 | CELC | Celcuity Inc. | 6.48B | 1.50% | 1,419,202 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.40B | -0.85% | 597,773 | 74.06M |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.38B | 1.93% | 1,113,780 | - |
| 39 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 1.91% | 1,370,036 | 569.61M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.16B | 5.55% | 1,417,252 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.13% | 922,345 | 15.00M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.13B | 3.94% | 1,211,040 | 827.11M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.05B | -5.01% | 757,901 | 217.17M |
| 44 | COGT | Cogent Biosciences, Inc. | 5.98B | -1.19% | 2,948,789 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.91B | -1.04% | 2,141,147 | - |
| 46 | BLTE | Belite Bio, Inc | 5.67B | -2.58% | 565,172 | - |
| 47 | CGON | CG Oncology, Inc. | 5.49B | 2.57% | 1,225,931 | 5.07M |
| 48 | CRSP | CRISPR Therapeutics AG | 5.42B | -0.35% | 1,932,828 | 4.10M |
| 49 | TGTX | TG Therapeutics, Inc. | 5.38B | -2.27% | 1,224,826 | 700.35M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | -0.11% | 1,375,299 | 7.50M |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.08B | 2.37% | 1,248,726 | 1.34M |
| 52 | LEGN | Legend Biotech Corporation | 5.04B | -3.89% | 2,452,180 | 1.14B |
| 53 | CAI | Caris Life Sciences, Inc. | 4.73B | 0.30% | 2,186,298 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.65B | -1.15% | 150,839 | 274.48M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.39B | -1.21% | 2,177,219 | 536.20M |
| 56 | MANE | Veradermics, Incorporated | 4.22B | -1.91% | 1,189,631 | - |
| 57 | ERAS | Erasca, Inc. | 3.99B | 5.25% | 6,386,102 | - |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.94B | -4.91% | 2,459,987 | 22.57M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | -0.19% | 2,605,155 | 596.96M |
| 60 | VKTX | Viking Therapeutics, Inc. | 3.80B | 1.71% | 1,747,728 | - |
| 61 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | -1.28% | 1,931,200 | 18.07M |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | 0.14% | 1,745,368 | 1.10B |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.68B | 2.58% | 1,167,042 | - |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.53B | 0.95% | 1,229,286 | - |
| 65 | DNLI | Denali Therapeutics Inc. | 3.34B | 0.43% | 1,695,632 | - |
| 66 | BEAM | Beam Therapeutics Inc. | 3.28B | 0.40% | 1,798,787 | 164.01M |
| 67 | DYN | Dyne Therapeutics, Inc. | 3.20B | 4.15% | 1,502,464 | - |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.19B | 3.51% | 2,182,168 | 236.00M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.18B | -1.05% | 140,968 | 803.79M |
| 70 | TNGX | Tango Therapeutics, Inc. | 3.18B | 9.90% | 3,412,991 | 56.99M |
| 71 | RLAY | Relay Therapeutics, Inc. | 3.06B | 1.08% | 3,468,593 | 10.68M |
| 72 | KLRA | Kailera Therapeutics, Inc. | 2.97B | -0.44% | 555,944 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 2.80B | -2.07% | 506,958 | - |
| 74 | ALMS | Alumis Inc. | 2.75B | 0.93% | 1,024,603 | 8.40M |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.68B | 0.09% | 1,629,709 | 415.62M |
| 76 | IRON | Disc Medicine, Inc. | 2.66B | -1.74% | 360,887 | - |
| 77 | DFTX | Definium Therapeutics, Inc. | 2.64B | 3.02% | 2,305,806 | - |
| 78 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | -0.13% | 1,091,521 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.59B | 0.44% | 1,097,842 | 225.27M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.55B | -0.24% | 615,990 | 535.08M |
| 81 | VERA | Vera Therapeutics, Inc. | 2.55B | -0.95% | 1,035,570 | - |
| 82 | IMNM | Immunome, Inc. | 2.47B | -3.15% | 1,727,997 | 4.02M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.47B | -0.85% | 494,672 | 865.00K |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.41B | -2.66% | 747,895 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.35B | 2.92% | 1,844,047 | 670.00M |
| 86 | KOD | Kodiak Sciences Inc. | 2.29B | 1.63% | 596,635 | - |
| 87 | NKTR | Nektar Therapeutics | 2.19B | -0.20% | 944,487 | 55.63M |
| 88 | PHVS | Pharvaris N.V. | 2.09B | 1.00% | 413,891 | - |
| 89 | NBTX | Nanobiotix S.A. | 2.02B | -0.02% | 39,166 | 38.27M |
| 90 | TRVI | Trevi Therapeutics, Inc. | 2.01B | -2.15% | 1,007,472 | - |
| 91 | MESO | Mesoblast Limited | 1.99B | 4.34% | 132,412 | 65.38M |
| 92 | ZLAB | Zai Lab Limited | 1.99B | -4.27% | 913,785 | 453.28M |
| 93 | TYRA | Tyra Biosciences, Inc. | 1.99B | 2.23% | 1,077,912 | - |
| 94 | OCUL | Ocular Therapeutix, Inc. | 1.98B | -1.53% | 2,405,075 | 52.04M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -0.13% | 1,304,731 | 298.30M |
| 96 | NTLA | Intellia Therapeutics, Inc. | 1.97B | 2.85% | 5,537,561 | 66.09M |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.95B | 0.97% | 1,395,910 | 70.92M |
| 98 | SION | Sionna Therapeutics, Inc. | 1.93B | 0.05% | 645,257 | - |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.93B | -2.21% | 543,777 | 32.08M |
| 100 | RXRX | Recursion Pharmaceuticals, Inc. | 1.90B | 4.36% | 29,983,555 | 66.41M |
| 101 | RAPP | Rapport Therapeutics, Inc. | 1.89B | 0.03% | 345,606 | 20.00M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | 3.29% | 3,653,704 | 2.18B |
| 103 | ABCL | AbCellera Biologics Inc. | 1.88B | 7.68% | 9,333,263 | 79.21M |
| 104 | LKFT | Lakefront Biotherapeutics NV | 1.88B | 0.21% | 117,841 | 1.20B |
| 105 | ADMA | ADMA Biologics, Inc. | 1.85B | 0.63% | 3,100,111 | 509.86M |
| 106 | AAPG | Ascentage Pharma Group International | 1.84B | 0.65% | 15,595 | 82.08M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.84B | 0.51% | 1,157,209 | 71.78M |
| 108 | ZYME | Zymeworks Inc. | 1.83B | -1.37% | 585,870 | 81.26M |
| 109 | IOVA | Iovance Biotherapeutics, Inc. | 1.83B | -4.65% | 17,279,249 | 285.61M |
| 110 | HRMY | Harmony Biosciences Holdings, Inc. | 1.83B | 0.32% | 1,035,492 | 899.11M |
| 111 | NVAX | Novavax, Inc. | 1.80B | 6.30% | 7,161,696 | 596.34M |
| 112 | QURE | uniQure N.V. | 1.80B | 14.81% | 3,554,734 | 18.09M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | -3.35% | 1,434,544 | 66.05M |
| 114 | CAPR | Capricor Therapeutics, Inc. | 1.74B | 2.92% | 841,137 | 11.13M |
| 115 | SNDX | Syndax Pharmaceuticals, Inc. | 1.73B | -0.81% | 862,046 | 217.17M |
| 116 | SLS | SELLAS Life Sciences Group, Inc. | 1.73B | 1.42% | 25,866,524 | - |
| 117 | VCEL | Vericel Corporation | 1.70B | -2.66% | 480,622 | 292.09M |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.70B | 2.24% | 155,621 | - |
| 119 | TSHA | Taysha Gene Therapies, Inc. | 1.69B | -0.84% | 2,155,624 | 7.47M |
| 120 | GENB | Generate Biomedicines, Inc. | 1.68B | 0.23% | 443,437 | 30.30M |
| 121 | GLUE | Monte Rosa Therapeutics, Inc. | 1.67B | 1.65% | 1,279,935 | 42.95M |
| 122 | NUVB | Nuvation Bio Inc. | 1.66B | 0.63% | 4,203,134 | 143.05M |
| 123 | ATAI | AtaiBeckley Inc. | 1.66B | 2.72% | 6,028,608 | 3.49M |
| 124 | BHVN | Biohaven Ltd. | 1.66B | 7.52% | 4,890,915 | - |
| 125 | GHRS | GH Research PLC | 1.65B | 7.19% | 318,494 | - |
| 126 | ANAB | AnaptysBio, Inc. | 1.62B | -2.37% | 502,180 | 232.39M |
| 127 | VIR | Vir Biotechnology, Inc. | 1.61B | -0.10% | 3,089,702 | 65.50M |
| 128 | INVA | Innoviva, Inc. | 1.58B | -2.15% | 1,164,233 | 420.69M |
| 129 | PGEN | Precigen, Inc. | 1.55B | -3.77% | 5,544,076 | 31.60M |
| 130 | IMTX | Immatics N.V. | 1.54B | 0.52% | 430,194 | 43.00M |
| 131 | DMRA | Damora Therapeutics, Inc. | 1.53B | 0.16% | 846,807 | - |
| 132 | INBX | Inhibrx Biosciences, Inc. | 1.53B | 0.03% | 245,097 | 1.30M |
| 133 | MBX | MBX Biosciences, Inc. | 1.50B | -1.35% | 821,395 | - |
| 134 | ARDX | Ardelyx, Inc. | 1.49B | -3.36% | 2,803,712 | 427.68M |
| 135 | IMCR | Immunocore Holdings plc | 1.47B | -0.28% | 605,152 | 412.81M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.46B | 0.23% | 674,490 | 20.00M |
| 137 | FTRE | Fortrea Holdings Inc. | 1.46B | 2.60% | 2,042,415 | 2.71B |
| 138 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.37% | 1,333,997 | 114.48M |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.43B | - | 348,671 | - |
| 140 | AVBP | ArriVent BioPharma, Inc. | 1.41B | 12.24% | 1,309,829 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.40B | 2.68% | 1,146,570 | - |
| 142 | URGN | UroGen Pharma Ltd. | 1.37B | -1.95% | 878,184 | 140.49M |
| 143 | SEPN | Septerna, Inc. | 1.36B | -2.74% | 270,509 | 72.26M |
| 144 | OCS | Oculis Holding AG | 1.34B | -23.42% | 2,856,634 | 1.51M |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -1.58% | 436,845 | - |
| 146 | SVRA | Savara Inc. | 1.32B | 2.16% | 2,236,381 | - |
| 147 | WVE | Wave Life Sciences Ltd. | 1.27B | 1.70% | 3,549,358 | 71.80M |
| 148 | COAG | Hemab Therapeutics Holdings, Inc. | 1.26B | 1.79% | 123,660 | - |
| 149 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.24B | 3.45% | 2,782,533 | 204.73M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.20B | 1.37% | 268,113 | - |
| 151 | MNKD | MannKind Corporation | 1.16B | 3.57% | 20,391,857 | 360.78M |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -0.86% | 724,805 | 10.00M |
| 153 | DBVT | DBV Technologies S.A. | 1.16B | 0.58% | 270,276 | 5.74M |
| 154 | OLMA | Olema Pharmaceuticals, Inc. | 1.15B | 3.37% | 1,607,340 | - |
| 155 | AKTS | Aktis Oncology, Inc. | 1.15B | 1.52% | 141,975 | 8.28M |
| 156 | EYPT | EyePoint, Inc. | 1.14B | 0.59% | 1,061,069 | 7.61M |
| 157 | ABSI | Absci Corporation | 1.05B | 11.02% | 9,580,181 | 1.84M |
| 158 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -0.72% | 3,399,029 | - |
| 159 | IVA | Inventiva S.A. | 1.04B | -5.74% | 76,178 | 7.94M |
| 160 | JBIO | Jade Biosciences, Inc. | 1.04B | 0.96% | 1,126,067 | - |
| 161 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 7.03% | 1,877,762 | - |
| 162 | MGTX | MeiraGTx Holdings plc | 986.29M | 6.50% | 2,288,648 | 79.76M |
| 163 | DRTS | Alpha Tau Medical Ltd. | 976.61M | 6.91% | 1,455,804 | - |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | 968.14M | -1.36% | 1,617,877 | 69.64M |
| 165 | SPTX | Seaport Therapeutics, Inc. | 964.58M | -3.24% | 112,573 | - |
| 166 | PHAR | Pharming Group N.V. | 949.84M | -4.90% | 21,756 | 369.49M |
| 167 | SANA | Sana Biotechnology, Inc. | 921.15M | 5.43% | 5,015,969 | - |
| 168 | KURA | Kura Oncology, Inc. | 905.50M | 2.31% | 1,722,071 | 71.64M |
| 169 | ABUS | Arbutus Biopharma Corporation | 900.77M | -0.87% | 2,383,728 | 191.45M |
| 170 | SPRY | ARS Pharmaceuticals, Inc. | 900.68M | -3.51% | 2,153,210 | 98.99M |
| 171 | JANX | Janux Therapeutics, Inc. | 889.76M | -1.02% | 1,051,851 | 13.73M |
| 172 | ANNX | Annexon, Inc. | 888.03M | 0.93% | 2,176,782 | - |
| 173 | XNCR | Xencor, Inc. | 880.80M | -0.75% | 647,066 | 97.36M |
| 174 | DRUG | Bright Minds Biosciences Inc. | 878.77M | -1.59% | 219,613 | - |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 873.69M | - | 3,978,569 | - |
| 176 | AVTX | Avalo Therapeutics, Inc. | 838.42M | -1.12% | 1,075,992 | 59.00K |
| 177 | EVMN | Evommune, Inc. | 836.71M | -0.43% | 493,269 | 10.00M |
| 178 | TBPH | Theravance Biopharma, Inc. | 827.94M | -0.93% | 531,200 | 109.78M |
| 179 | AURA | Aura Biosciences, Inc. | 823.94M | -0.40% | 438,933 | - |
| 180 | VOR | Vor Biopharma Inc. | 811.16M | -0.27% | 479,791 | - |
| 181 | ODTX | Odyssey Therapeutics, Inc. | 802.43M | -5.69% | 165,302 | 2.98M |
| 182 | LBRX | LB Pharmaceuticals Inc | 802.09M | 1.60% | 358,025 | - |
| 183 | GERN | Geron Corporation | 801.90M | - | 11,696,926 | 196.12M |
| 184 | OMER | Omeros Corporation | 799.02M | -0.99% | 2,596,693 | 9.89M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 783.73M | -2.96% | 2,627,144 | 35.54M |
| 186 | PHAT | Phathom Pharmaceuticals, Inc. | 761.73M | -7.07% | 1,653,985 | 204.89M |
| 187 | RLMD | Relmada Therapeutics, Inc. | 756.24M | -0.55% | 946,332 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 748.99M | -3.56% | 10,289,539 | 22.00K |
| 189 | SLDB | Solid Biosciences Inc. | 723.11M | 3.82% | 1,268,308 | - |
| 190 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 718.56M | 1.47% | 246,379 | - |
| 191 | REPL | Replimune Group, Inc. | 717.97M | 85.68% | 51,373,361 | - |
| 192 | ANRO | Alto Neuroscience, Inc. | 703.51M | -0.74% | 170,976 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 699.47M | 1.54% | 390,672 | - |
| 194 | CBIO | Crescent Biopharma, Inc. | 686.18M | -3.82% | 419,765 | 11.88M |
| 195 | ZVRA | Zevra Therapeutics, Inc. | 685.73M | 1.67% | 2,260,666 | 122.29M |
| 196 | CRMD | CorMedix Inc. | 662.13M | 0.24% | 1,041,247 | 400.05M |
| 197 | DSGN | Design Therapeutics, Inc. | 654.55M | -2.42% | 1,595,146 | - |
| 198 | SGP | SpyGlass Pharma, Inc. | 643.80M | -2.92% | 44,587 | - |
| 199 | PRME | Prime Medicine, Inc. | 641.19M | 4.41% | 3,337,658 | 4.03M |
| 200 | ACRS | Aclaris Therapeutics, Inc. | 635.47M | -0.44% | 1,184,479 | 8.37M |
| 201 | IMMX | Immix Biopharma, Inc. | 628.12M | 1.81% | 964,011 | - |
| 202 | CABA | Cabaletta Bio, Inc. | 616.35M | 0.27% | 2,536,942 | - |
| 203 | DNA | Ginkgo Bioworks Holdings, Inc. | 612.09M | -0.95% | 1,183,083 | 151.40M |
| 204 | CADL | Candel Therapeutics, Inc. | 608.14M | 2.60% | 1,366,204 | - |
| 205 | ALT | Altimmune, Inc. | 593.15M | -0.65% | 2,596,555 | 36.00K |
| 206 | TECX | Tectonic Therapeutic, Inc. | 589.66M | 4.65% | 336,390 | - |
| 207 | EIKN | Eikon Therapeutics, Inc. | 586.86M | 5.24% | 200,799 | - |
| 208 | ARVN | Arvinas, Inc. | 579.40M | 1.58% | 795,934 | 89.40M |
| 209 | VALN | Valneva SE | 578.55M | -0.79% | 73,582 | 180.25M |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 564.13M | 1.46% | 350,209 | 299.77M |
| 211 | TRAX | First Tracks Biotherapeutics, Inc. | 556.88M | 0.88% | 471,518 | - |
| 212 | AGMB | AgomAb Therapeutics NV | 554.04M | -2.51% | 17,437 | - |
| 213 | PROK | ProKidney Corp. | 549.75M | 1.10% | 1,003,655 | 889.00K |
| 214 | ASMB | Assembly Biosciences, Inc. | 548.15M | -0.25% | 138,760 | 71.10M |
| 215 | MDXG | MiMedx Group, Inc. | 548.12M | 0.27% | 3,291,828 | 389.42M |
| 216 | GYRE | Gyre Therapeutics, Inc. | 540.01M | 2.96% | 107,665 | 117.05M |
| 217 | ACHV | Achieve Life Sciences, Inc. | 537.93M | -1.13% | 1,099,042 | - |
| 218 | PRTA | Prothena Corporation plc | 532.96M | 2.00% | 501,434 | 57.94M |
| 219 | EDIT | Editas Medicine, Inc. | 530.98M | 0.87% | 3,912,556 | 38.69M |
| 220 | CLYM | Climb Bio, Inc. | 523.54M | -3.35% | 605,207 | - |
| 221 | XOMA | XOMA Royalty Corporation | 523.21M | 0.02% | 78,260 | 48.56M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 518.06M | 10.48% | 3,316,845 | 88.24M |
| 223 | KYTX | Kyverna Therapeutics, Inc. | 515.72M | -1.50% | 614,881 | - |
| 224 | CTNM | Contineum Therapeutics, Inc. | 504.34M | 1.35% | 100,732 | - |
| 225 | AUTL | Autolus Therapeutics plc | 497.69M | 5.65% | 2,402,544 | 92.62M |
| 226 | CCCC | C4 Therapeutics, Inc. | 481.49M | 19.40% | 5,891,767 | 34.86M |
| 227 | STRO | Sutro Biopharma, Inc. | 478.15M | -1.35% | 212,144 | 102.48M |
| 228 | ANL | Adlai Nortye Ltd. | 477.60M | 5.04% | 105,592 | 5.00M |
| 229 | OVID | Ovid Therapeutics Inc. | 472.39M | 3.41% | 1,672,992 | 7.12M |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.57M | -3.93% | 194,162 | - |
| 231 | OCGN | Ocugen, Inc. | 467.16M | -2.13% | 12,730,170 | 4.47M |
| 232 | FBRX | Forte Biosciences, Inc. | 465.99M | -8.18% | 392,913 | - |
| 233 | FULC | Fulcrum Therapeutics, Inc. | 461.10M | 1.47% | 391,024 | 80.00M |
| 234 | STTK | Shattuck Labs, Inc. | 455.48M | -0.59% | 1,044,004 | 1.00M |
| 235 | UPB | Upstream Bio, Inc. | 454.95M | 0.48% | 499,059 | 3.32M |
| 236 | SGMT | Sagimet Biosciences Inc. | 450.17M | 0.28% | 628,235 | - |
| 237 | NGNE | Neurogene Inc. | 445.46M | 3.05% | 98,375 | 925.00K |
| 238 | IPSC | Century Therapeutics, Inc. | 441.87M | 2.73% | 1,196,088 | 109.16M |
| 239 | MNPR | Monopar Therapeutics Inc. | 435.69M | 0.95% | 119,439 | - |
| 240 | ADCT | ADC Therapeutics SA | 432.45M | -1.45% | 689,879 | 79.18M |
| 241 | CMPX | Compass Therapeutics, Inc. | 428.61M | -1.24% | 6,051,062 | 850.00K |
| 242 | VTVT | vTv Therapeutics Inc. | 413.86M | -0.45% | 21,371 | 36.84M |
| 243 | ZURA | Zura Bio Limited | 407.99M | 2.62% | 474,502 | - |
| 244 | XFOR | X4 Pharmaceuticals, Inc. | 406.52M | 4.11% | 878,517 | 9.01M |
| 245 | LYEL | Lyell Immunopharma, Inc. | 404.38M | 2.97% | 65,619 | 31.00K |
| 246 | LXEO | Lexeo Therapeutics, Inc. | 403.60M | 1.18% | 666,771 | - |
| 247 | BNTC | Benitec Biopharma Inc. | 397.14M | - | 82,475 | - |
| 248 | PRLD | Prelude Therapeutics Incorporated | 394.27M | -0.25% | 288,208 | 16.72M |
| 249 | OABI | OmniAb, Inc. | 391.43M | -0.74% | 456,001 | 28.94M |
| 250 | VNDA | Vanda Pharmaceuticals Inc. | 387.87M | -2.86% | 809,463 | 217.78M |
| 251 | ARTV | Artiva Biotherapeutics, Inc. | 385.30M | 4.20% | 707,550 | 251.00K |
| 252 | ENTA | Enanta Pharmaceuticals, Inc. | 382.67M | -0.53% | 187,996 | 69.21M |
| 253 | VSTM | Verastem, Inc. | 380.49M | 0.93% | 2,106,013 | 49.59M |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 373.73M | -1.27% | 319,072 | - |
| 255 | IMRX | Immuneering Corporation | 373.30M | 14.03% | 2,947,492 | - |
| 256 | PBYI | Puma Biotechnology, Inc. | 364.69M | -0.97% | 205,854 | 227.18M |
| 257 | RGNX | REGENXBIO Inc. | 363.43M | 1.74% | 1,127,892 | 87.82M |
| 258 | LRMR | Larimar Therapeutics, Inc. | 363.25M | -0.29% | 1,293,708 | - |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 362.64M | -9.71% | 199,527 | - |
| 260 | PALI | Palisade Bio, Inc. | 354.94M | 2.91% | 751,894 | - |
| 261 | IFRX | InflaRx N.V. | 353.50M | 0.84% | 669,666 | 33.82K |
| 262 | NAUT | Nautilus Biotechnology, Inc. | 348.20M | 5.38% | 544,943 | - |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 344.94M | 0.40% | 447,840 | 51.00M |
| 264 | RZLT | Rezolute, Inc. | 344.74M | 0.92% | 1,503,674 | - |
| 265 | NMRA | Neumora Therapeutics, Inc. | 337.97M | -1.60% | 892,364 | - |
| 266 | IVVD | Invivyd, Inc. | 335.85M | 0.88% | 3,395,293 | 55.87M |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 335.22M | 1.66% | 2,262,421 | - |
| 268 | LCTX | Lineage Cell Therapeutics, Inc. | 331.57M | - | 639,321 | 14.78M |
| 269 | FATE | Fate Therapeutics, Inc. | 331.03M | 7.98% | 5,193,548 | 6.32M |
| 270 | ABEO | Abeona Therapeutics Inc. | 329.43M | - | 714,738 | 14.54M |
| 271 | BCYC | Bicycle Therapeutics plc | 327.41M | 0.43% | 162,660 | 63.50M |
| 272 | SLN | Silence Therapeutics plc | 326.16M | 0.66% | 210,050 | 839.00K |
| 273 | DMAC | DiaMedica Therapeutics Inc. | 322.76M | -2.76% | 214,614 | - |
| 274 | IRD | Opus Genetics, Inc. | 311.31M | 3.81% | 977,385 | 11.98M |
| 275 | NAGE | Niagen Bioscience, Inc. | 308.07M | 0.52% | 1,910,283 | 130.42M |
| 276 | SRZN | Surrozen, Inc. | 304.31M | -0.80% | 360,316 | 7.49M |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 299.80M | 0.62% | 96,355 | 5.20M |
| 278 | IKT | Inhibikase Therapeutics, Inc. | 298.24M | -1.13% | 306,262 | 1.00 |
| 279 | CNXU | Conexeu Sciences Inc. | 296.29M | 1.25% | 30,539 | - |
| 280 | ELDN | Eledon Pharmaceuticals, Inc. | 294.52M | -1.55% | 794,679 | - |
| 281 | HUMA | Humacyte, Inc. | 288.62M | 1.56% | 9,420,696 | 2.02M |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 284.75M | -1.23% | 676,524 | 26.87M |
| 283 | AVXL | Anavex Life Sciences Corp. | 280.80M | 3.06% | 1,314,586 | - |
| 284 | MGNX | MacroGenics, Inc. | 264.41M | -1.19% | 597,487 | 157.08M |
| 285 | ACIU | AC Immune SA | 263.88M | -3.27% | 293,045 | 4.62M |
| 286 | ADAG | Adagene Inc. | 262.31M | 0.76% | 553,216 | 7.67M |
| 287 | CNTX | Context Therapeutics Inc. | 261.86M | 0.71% | 552,066 | - |
| 288 | TARA | Protara Therapeutics, Inc. | 261.35M | -2.11% | 554,699 | - |
| 289 | CLLS | Cellectis S.A. | 260.79M | -3.03% | 53,477 | 75.11M |
| 290 | NVCT | Nuvectis Pharma, Inc. | 258.62M | -4.32% | 105,327 | - |
| 291 | ALXO | ALX Oncology Holdings Inc. | 255.66M | 0.53% | 704,780 | - |
| 292 | TRDA | Entrada Therapeutics, Inc. | 254.76M | 3.67% | 277,956 | 5.74M |
| 293 | SABS | SAB Biotherapeutics, Inc. | 252.99M | 0.84% | 223,666 | 114.70K |
| 294 | CDXS | Codexis, Inc. | 251.78M | 0.73% | 995,820 | 78.09M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 251.30M | 0.23% | 104,936 | 28.22M |
| 296 | CGEN | Compugen Ltd. | 248.76M | -5.40% | 373,857 | 72.66M |
| 297 | CHRS | Coherus Oncology, Inc. | 245.26M | -3.64% | 1,532,142 | 46.88M |
| 298 | LENZ | LENZ Therapeutics, Inc. | 243.94M | -2.63% | 1,018,572 | 20.99M |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 241.45M | -1.89% | 38,921 | 18.47M |
| 300 | ALEC | Alector, Inc. | 239.81M | 0.47% | 993,189 | 18.42M |
| 301 | OBIO | Orchestra BioMed Holdings, Inc. | 234.13M | -1.76% | 192,999 | 32.72M |
| 302 | VYGR | Voyager Therapeutics, Inc. | 233.83M | -0.77% | 448,213 | 36.49M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 233.30M | -1.26% | 220,301 | 7.15M |
| 304 | NKTX | Nkarta, Inc. | 232.16M | -1.52% | 342,761 | - |
| 305 | CRBU | Caribou Biosciences, Inc. | 231.89M | 2.16% | 1,394,446 | 11.20M |
| 306 | NERV | Minerva Neurosciences, Inc. | 228.75M | -1.80% | 58,159 | - |
| 307 | CAMP | Camp4 Therapeutics Corporation | 227.95M | -2.23% | 50,910 | 3.93M |
| 308 | HELP | Cybin Inc. | 227.66M | 1.34% | 385,033 | - |
| 309 | YDES | YD Bio Limited | 226.43M | -8.26% | 12,779 | 510.36K |
| 310 | ARCT | Arcturus Therapeutics Holdings Inc. | 225.11M | - | 411,191 | 54.71M |
| 311 | KROS | Keros Therapeutics, Inc. | 222.66M | -1.23% | 162,928 | 33.18M |
| 312 | RNA | Atrium Therapeutics, Inc. | 222.37M | -2.69% | 321,203 | 36.68M |
| 313 | RNAC | Cartesian Therapeutics, Inc. | 221.54M | 4.58% | 237,999 | 1.78M |
| 314 | NGEN | NervGen Pharma Corp. | 219.84M | -0.48% | 973,382 | - |
| 315 | NBP | NovaBridge Biosciences | 212.79M | -1.60% | 361,355 | - |
| 316 | ELTX | Elicio Therapeutics, Inc. | 210.45M | 7.82% | 91,705 | - |
| 317 | KPTI | Karyopharm Therapeutics Inc. | 205.22M | -0.11% | 290,708 | 151.12M |
| 318 | IMUX | Immunic, Inc. | 203.78M | -0.07% | 366,560 | - |
| 319 | INDP | Indaptus Therapeutics, Inc. | 199.31M | 22.22% | 102,956 | - |
| 320 | UNCY | Unicycive Therapeutics, Inc. | 197.05M | 5.13% | 610,128 | - |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 196.55M | -2.45% | 421,773 | 17.56M |
| 322 | ENLV | Enlivex Ltd. | 195.32M | 6.00% | 754,728 | - |
| 323 | KRRO | Korro Bio, Inc. | 193.41M | 0.07% | 118,152 | 3.84M |
| 324 | MIST | Milestone Pharmaceuticals Inc. | 193.19M | -1.39% | 520,241 | 1.78M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 188.57M | 8.77% | 5,087,682 | 225.00K |
| 326 | ABOS | Acumen Pharmaceuticals, Inc. | 187.79M | 2.36% | 189,582 | - |
| 327 | QTTB | Q32 Bio Inc. | 187.37M | 7.18% | 1,202,908 | 53.74M |
| 328 | MDWD | MediWound Ltd. | 184.17M | -1.58% | 161,621 | 14.48M |
| 329 | EQ | Equillium, Inc. | 183.36M | 2.11% | 855,288 | 4.39M |
| 330 | TLSA | Tiziana Life Sciences Ltd | 182.32M | -3.42% | 228,203 | - |
| 331 | DTIL | Precision BioSciences, Inc. | 179.84M | 0.72% | 266,074 | 45.07M |
| 332 | IPHA | Innate Pharma S.A. | 176.66M | 5.17% | 10,474 | 10.57M |
| 333 | CNTN | Canton Strategic Holdings, Inc. | 175.63M | -0.32% | 754,958 | - |
| 334 | OKUR | OnKure Therapeutics, Inc. | 170.47M | 2.18% | 88,760 | - |
| 335 | PLX | Protalix BioTherapeutics, Inc. | 170.01M | 0.48% | 487,911 | 76.38M |
| 336 | PRQR | ProQR Therapeutics N.V. | 166.47M | 0.64% | 684,588 | 15.73M |
| 337 | GALT | Galectin Therapeutics Inc. | 165.96M | -1.95% | 282,376 | - |
| 338 | HRTX | Heron Therapeutics, Inc. | 164.69M | -2.44% | 1,832,479 | 150.71M |
| 339 | SPRO | Spero Therapeutics, Inc. | 163.57M | -2.41% | 1,340,207 | 61.19M |
| 340 | MENS | Jyong Biotech Ltd. | 163.31M | -2.22% | 27,846 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 162.48M | 0.25% | 122,012 | 2.00M |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 159.99M | -0.45% | 1,247,940 | 2.29M |
| 343 | ANTX | AN2 Therapeutics, Inc. | 155.86M | -2.91% | 112,292 | - |
| 344 | TTRX | Turn Therapeutics Inc. | 154.90M | -2.07% | 145,131 | - |
| 345 | PLYX | Polaryx Therapeutics, Inc. | 154.81M | 7.21% | 564,530 | - |
| 346 | MOLN | Molecular Partners AG | 150.29M | 4.92% | 1,191 | 856.30K |
| 347 | KZIA | Kazia Therapeutics Limited | 146.04M | 0.87% | 148,180 | 1.27M |
| 348 | AGEN | Agenus Inc. | 145.38M | 2.94% | 617,262 | 123.87M |
| 349 | HURA | TuHURA Biosciences, Inc. | 143.92M | -3.83% | 468,743 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 140.74M | 4.62% | 267,182 | 233.00K |
| 351 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.30M | 3.53% | 1,056,127 | - |
| 352 | SPRB | Spruce Biosciences, Inc. | 140.28M | 4.23% | 54,329 | 697.00K |
| 353 | GNLX | Genelux Corporation | 135.45M | -0.65% | 115,163 | 8.00K |
| 354 | ACOG | Alpha Cognition Inc. | 134.78M | 4.21% | 113,120 | 10.83M |
| 355 | CRDF | Cardiff Oncology, Inc. | 129.90M | 3.26% | 785,531 | 525.00K |
| 356 | GUTS | Fractyl Health, Inc. | 127.90M | -4.14% | 1,595,657 | 3.00K |
| 357 | BDTX | Black Diamond Therapeutics, Inc. | 127.21M | -1.33% | 2,167,786 | 70.00M |
| 358 | ALPS | Alps Group Inc | 126.45M | -1.31% | 16,479 | 3.74M |
| 359 | ENGN | enGene Therapeutics Inc. | 123.93M | 3.93% | 1,108,408 | - |
| 360 | KLRS | Kalaris Therapeutics, Inc. | 121.17M | 1.74% | 144,881 | - |
| 361 | ONCY | Oncolytics Biotech Inc. | 120.77M | 11.23% | 2,878,815 | - |
| 362 | NTHI | NeOnc Technologies Holdings, Inc. | 117.47M | -3.13% | 28,334 | 39.99K |
| 363 | VANI | Vivani Medical, Inc. | 114.69M | 2.33% | 146,729 | - |
| 364 | PYXS | Pyxis Oncology, Inc. | 114.04M | 1.12% | 299,019 | 13.86M |
| 365 | COYA | Coya Therapeutics, Inc. | 113.06M | -0.21% | 118,693 | 7.94M |
| 366 | CBUS | Cibus, Inc. | 109.85M | -0.69% | 216,655 | 3.64M |
| 367 | INO | Inovio Pharmaceuticals, Inc. | 107.34M | 0.77% | 1,151,802 | 65.34K |
| 368 | ALDX | Aldeyra Therapeutics, Inc. | 105.56M | - | 579,896 | - |
| 369 | SEER | Seer, Inc. | 105.51M | -3.11% | 215,256 | 16.58M |
| 370 | CGTX | Cognition Therapeutics, Inc. | 105.44M | -0.84% | 682,322 | - |
| 371 | PEPG | PepGen Inc. | 103.75M | - | 596,057 | - |
| 372 | RNTX | Rein Therapeutics Inc. | 103.27M | - | 545,278 | - |
| 373 | BMEA | Biomea Fusion, Inc. | 99.77M | - | 516,530 | - |
| 374 | VRCA | Verrica Pharmaceuticals Inc. | 98.95M | -4.64% | 35,663 | 37.16M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 98.55M | 1.10% | 46,635 | - |
| 376 | ACET | Adicet Bio, Inc. | 97.76M | 7.75% | 203,827 | - |
| 377 | OSTX | OS Therapies Incorporated | 95.31M | 8.08% | 1,457,695 | - |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 94.90M | -0.07% | 1,007,858 | 3.17M |
| 379 | FBIO | Fortress Biotech, Inc. | 93.01M | -0.36% | 354,636 | 66.16M |
| 380 | PTHS | Pelthos Therapeutics Inc. | 92.00M | 2.60% | 10,394 | 27.70M |
| 381 | ICCC | ImmuCell Corporation | 91.55M | 2.22% | 29,834 | 29.93M |
| 382 | ANIX | Anixa Biosciences, Inc. | 90.53M | - | 93,642 | - |
| 383 | PYPD | PolyPid Ltd. | 90.07M | -0.84% | 55,273 | - |
| 384 | OKYO | OKYO Pharma Limited | 90.00M | 0.29% | 27,402 | - |
| 385 | AARD | Aardvark Therapeutics, Inc. | 89.67M | -2.14% | 149,703 | - |
| 386 | LONA | LeonaBio, Inc. | 89.61M | 0.16% | 9,794 | - |
| 387 | ATRA | Atara Biotherapeutics, Inc. | 89.46M | -6.66% | 96,378 | 23.14M |
| 388 | OTLK | Outlook Therapeutics, Inc. | 88.23M | -1.35% | 31,623,092 | 333.14K |
| 389 | HYFT | MindWalk Holdings Corp. | 87.41M | -1.68% | 299,679 | 20.70M |
| 390 | NRXS | NeurAxis, Inc. | 85.26M | 1.65% | 73,116 | 4.28M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 84.51M | 7.75% | 1,121,306 | - |
| 392 | EXOZ | eXoZymes, Inc. | 83.48M | 1.29% | 3,968 | -700.00 |
| 393 | GANX | Gain Therapeutics, Inc. | 83.18M | -3.47% | 868,683 | - |
| 394 | ANVS | Annovis Bio, Inc. | 81.68M | 1.05% | 960,231 | - |
| 395 | CSBR | Champions Oncology, Inc. | 81.03M | -0.26% | 12,342 | 57.95M |
| 396 | PLRX | Pliant Therapeutics, Inc. | 78.02M | 0.80% | 315,279 | - |
| 397 | RLYB | Rallybio Corporation | 77.18M | -0.41% | 45,935 | 858.00K |
| 398 | FLNA | Filana Therapeutics, Inc. | 74.39M | -0.65% | 511,596 | - |
| 399 | XBIT | XBiotech Inc. | 73.78M | -0.82% | 44,007 | - |
| 400 | LIXT | Lixte Biotechnology Holdings, Inc. | 72.61M | 4.34% | 40,306 | - |
| 401 | CUE | Cue Biopharma, Inc. | 71.29M | -3.27% | 87,631 | 32.73M |
| 402 | MCRB | Seres Therapeutics, Inc. | 70.89M | -2.37% | 41,792 | 1.15M |
| 403 | TCRX | TScan Therapeutics, Inc. | 70.58M | - | 208,342 | 9.14M |
| 404 | ATHE | Alterity Therapeutics Limited | 70.41M | 0.98% | 21,054 | 4.43M |
| 405 | BYSI | BeyondSpring Inc. | 69.08M | -2.33% | 16,513 | 1.88M |
| 406 | IBIO | iBio, Inc. | 68.67M | -1.55% | 324,272 | 300.00K |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 68.48M | -1.84% | 366,751 | - |
| 408 | MNOV | MediciNova, Inc. | 66.94M | -0.73% | 35,217 | 596.64K |
| 409 | ENTX | Entera Bio Ltd. | 66.45M | 10.66% | 167,972 | 42.00K |
| 410 | IMA | ImageneBio, Inc. | 66.32M | -0.84% | 10,724 | 800.00K |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 64.26M | 0.84% | 409,856 | - |
| 412 | EDSA | Edesa Biotech, Inc. | 64.15M | -8.14% | 246,578 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 60.78M | - | 63,916 | - |
| 414 | PDSB | PDS Biotechnology Corporation | 60.28M | 0.93% | 826,610 | - |
| 415 | DWTX | Dogwood Therapeutics, Inc. | 56.45M | 1.20% | 27,506 | - |
| 416 | IMMP | Immutep Limited | 56.18M | -1.28% | 678,493 | 5.28M |
| 417 | IBO | Impact BioMedical Inc. | 56.07M | 1.15% | 27,721 | 39.00K |
| 418 | CING | Cingulate Inc. | 55.23M | -4.15% | 1,040,558 | - |
| 419 | MREO | Mereo BioPharma Group plc | 54.91M | -0.29% | 3,892,498 | 500.00K |
| 420 | TIL | Instil Bio, Inc. | 54.73M | -0.37% | 16,297 | - |
| 421 | GOSS | Gossamer Bio, Inc. | 54.19M | 9.38% | 13,216,337 | 55.54M |
| 422 | ATYR | aTyr Pharma, Inc. | 53.19M | 11.30% | 5,434,479 | 190.00K |
| 423 | MGX | Metagenomi Therapeutics, Inc. | 51.20M | -2.86% | 188,317 | 22.33M |
| 424 | RADX | Radiopharm Theranostics Limited | 50.99M | -0.87% | 11,575 | 10.86M |
| 425 | XLO | Xilio Therapeutics, Inc. | 50.70M | -0.53% | 23,431 | 53.48M |
| 426 | HYPD | Hyperion DeFi, Inc. | 49.72M | 1.74% | 645,842 | 1.04M |
| 427 | ACTU | Actuate Therapeutics, Inc. | 48.33M | -2.88% | 102,386 | - |
| 428 | ESLA | Estrella Immunopharma, Inc. | 46.91M | -4.39% | 7,725 | - |
| 429 | ATOS | Atossa Therapeutics, Inc. | 45.04M | 0.77% | 42,865 | - |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | 1.56% | 128,555 | - |
| 431 | QNTM | Quantum BioPharma Ltd. | 44.10M | -2.28% | 196,794 | - |
| 432 | NTRB | Nutriband Inc. | 42.42M | -4.25% | 17,892 | 2.04M |
| 433 | KALA | KALA BIO, Inc. | 41.46M | -2.62% | 61,752 | - |
| 434 | RNXT | RenovoRx, Inc. | 40.98M | -8.05% | 317,400 | 1.49M |
| 435 | NNVC | NanoViricides, Inc. | 40.55M | -4.30% | 1,105,487 | - |
| 436 | LTRN | Lantern Pharma Inc. | 40.24M | 2.57% | 116,542 | - |
| 437 | PSTV | Plus Therapeutics, Inc. | 39.94M | -9.49% | 191,469 | 5.21M |
| 438 | GRCE | Grace Therapeutics, Inc. | 39.77M | 5.76% | 418,411 | - |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 39.28M | 9.57% | 184,606 | 90.00K |
| 440 | VERU | Veru Inc. | 38.04M | 2.16% | 68,912 | 16.89M |
| 441 | INMB | INmune Bio Inc. | 37.49M | -0.70% | 303,320 | 50.00K |
| 442 | GRDX | GridAI Technologies Corp. | 37.32M | 13.33% | 235,720 | - |
| 443 | ABVC | ABVC BioPharma, Inc. | 35.63M | - | 91,381 | 797.92K |
| 444 | ALGS | Aligos Therapeutics, Inc. | 35.27M | -1.55% | 106,386 | 4.71M |
| 445 | LITS | Lite Strategy, Inc. | 34.37M | -0.98% | 269,715 | - |
| 446 | DARE | Daré Bioscience, Inc. | 33.40M | -2.19% | 170,558 | 1.16M |
| 447 | EVAX | Evaxion A/S | 33.36M | -2.44% | 19,106 | 7.53M |
| 448 | TVGN | Tevogen Bio Holdings Inc. | 33.19M | -3.36% | 25,768 | - |
| 449 | BOLD | Boundless Bio, Inc. | 32.51M | -0.68% | 45,309 | - |
| 450 | PLRZ | Polyrizon Ltd. | 32.14M | 4.06% | 35,652 | - |
| 451 | TVRD | Tvardi Therapeutics, Inc. | 31.71M | -2.58% | 54,242 | - |
| 452 | APLM | Apollomics, Inc. | 31.07M | 0.64% | 21,213 | 8.84M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 29.64M | -4.84% | 173,084 | 38.00K |
| 454 | DYAI | Dyadic International, Inc. | 29.44M | 13.80% | 811,501 | 3.81M |
| 455 | LSTA | Lisata Therapeutics, Inc. | 29.35M | -1.52% | 1,763,242 | 170.00K |
| 456 | CELU | Celularity Inc. | 29.24M | 1.92% | 74,610 | 26.55M |
| 457 | NRSN | NeuroSense Therapeutics Ltd. | 29.04M | -4.49% | 125,312 | - |
| 458 | CRVO | CervoMed Inc. | 28.79M | -0.64% | 75,410 | 2.09M |
| 459 | NEUP | Neuphoria Therapeutics Inc. | 28.70M | -0.93% | 20,300 | -13.27K |
| 460 | IGC | IGC Pharma, Inc. | 28.54M | -0.28% | 262,835 | 1.11M |
| 461 | SNSE | Sensei Biotherapeutics, Inc. | 28.37M | 20.18% | 69,932 | - |
| 462 | KYNB | Kyntra Bio, Inc. | 27.93M | -1.25% | 6,646 | 7.44M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 27.81M | -0.37% | 2,343 | 14.97M |
| 464 | SER | Serina Therapeutics, Inc. | 27.41M | -5.64% | 55,415 | 130.00K |
| 465 | SKYE | Skye Bioscience, Inc. | 27.24M | -8.77% | 452,070 | - |
| 466 | BCTX | BriaCell Therapeutics Corp. | 26.46M | 1.68% | 145,255 | - |
| 467 | MRKR | Marker Therapeutics, Inc. | 26.18M | 3.97% | 92,276 | 3.55M |
| 468 | PTN | Palatin Technologies, Inc. | 25.97M | 0.14% | 7,670 | 12.88M |
| 469 | ALLR | Allarity Therapeutics, Inc. | 25.36M | -1.80% | 215,090 | 345.00K |
| 470 | CLRB | Cellectar Biosciences, Inc. | 25.09M | - | 277,613 | - |
| 471 | PLUR | Pluri Inc. | 25.03M | -1.28% | 31,234 | 1.08M |
| 472 | VTGN | Vistagen Therapeutics, Inc. | 24.96M | -0.52% | 653,671 | 789.00K |
| 473 | GNTA | Genenta Science S.p.A. | 24.30M | 15.08% | 836,180 | - |
| 474 | KTTA | Pasithea Therapeutics Corp. | 23.90M | 2.89% | 1,546,019 | - |
| 475 | JSPR | Jasper Therapeutics, Inc. | 23.21M | -6.90% | 337,863 | - |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.72M | -0.73% | 75,212 | 454.00K |
| 477 | CRIS | Curis, Inc. | 22.67M | 8.33% | 365,763 | 7.06M |
| 478 | LGVN | Longeveron Inc. | 22.61M | -5.24% | 181,433 | 1.22M |
| 479 | NXTC | NextCure, Inc. | 22.37M | -3.13% | 11,495 | - |
| 480 | CVM | CEL-SCI Corporation | 22.32M | 4.05% | 189,289 | - |
| 481 | TRAW | Traws Pharma, Inc. | 22.12M | -3.95% | 379,792 | 2.73M |
| 482 | TPST | Tempest Therapeutics, Inc. | 22.09M | -11.56% | 240,484 | - |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 21.87M | -1.32% | 281,516 | 1.14M |
| 484 | XCUR | Exicure, Inc. | 20.33M | 7.41% | 15,163 | 500.00K |
| 485 | AEON | AEON Biopharma, Inc. | 19.91M | 5.64% | 35,283 | - |
| 486 | NCEL | NewcelX Ltd. | 18.95M | -0.56% | 28,150 | - |
| 487 | AKTX | Akari Therapeutics, Plc | 18.81M | -25.49% | 546,675 | - |
| 488 | QNCX | Quince Therapeutics, Inc. | 18.75M | -1.71% | 710,620 | - |
| 489 | PASG | Passage Bio, Inc. | 18.51M | 1.05% | 29,678 | - |
| 490 | INAB | IN8bio, Inc. | 18.41M | 3.89% | 93,622 | - |
| 491 | LPCN | Lipocine Inc. | 18.06M | -0.44% | 82,749 | 2.00M |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 17.98M | 0.31% | 380,123 | 5.61M |
| 493 | GTBP | GT Biopharma, Inc. | 17.25M | 7.36% | 3,453,027 | - |
| 494 | HIND | Vyome Holdings, Inc. | 16.42M | -0.43% | 21,810 | 152.72K |
| 495 | MLEC | Moolec Science SA | 15.66M | 4.58% | 36,492 | 7.83M |
| 496 | COCP | Cocrystal Pharma, Inc. | 15.44M | -0.88% | 103,944 | 225.00K |
| 497 | OSRH | OSR Holdings, Inc. | 15.29M | -5.28% | 1,229,134 | 2.63M |
| 498 | CVKD | Cadrenal Therapeutics, Inc. | 15.27M | -0.80% | 28,016 | - |
| 499 | BLRX | BioLineRx Ltd. | 14.95M | 5.29% | 106,751 | 1.40M |
| 500 | LEXX | Lexaria Bioscience Corp. | 14.92M | -2.92% | 61,780 | 368.00K |